References
- Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349–356.
- Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol 2003;42:761–778.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.
- Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 1996;34:918–923.
- Sáez M, García-Bustínduy M, Noda A, Dorta S, Escoda M, Fagundo E et al. Drug-induced Sweet’s syndrome. J Eur Acad Dermatol Venereol 2004;18:233.
- Roujeau JC. Neutrophilic drug eruptions. Clin Dermatol 2000;18:331–337.
- Thompson DF, Montarella KE. Drug-induced Sweet’s syndrome. Ann Pharmacother 2007;41:802–811.
- Epelde F, Boada L. Leukocytoclastic vasculitis and hemoptysis after treatment with aceclofenac. Ann Pharmacother 1995;29:1168.
- Linares T, Marcos C, Gavilan MJ, Arenas L. Fixed drug eruption due to aceclofenac. Contact Derm 2007;56:291–292.
- Ludwig C, Brinkmeier T, Frosch PJ. [Exudative erythema multiforme with transition to a toxic epidermal necrolysis after taking aceclofenac (Beofenac)]. Dtsch Med Wochenschr 2003;128:487–490.